Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 1
2015 1
2016 1
2021 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol.
Rogé M, Pointreau Y, Sargos P, Meyer E, Schick U, Hasbini A, Rio E, Bera G, Ruffier A, Quivrin M, Chasseray M, Latorzeff I, Martin E, Guimas V, Pommier P, Leroy T, Ronchin P, Lepinoy A, Grand A, Cartier L, Didas O, Denis F, Libois V, Blanc-Lapierre A, Supiot S. Rogé M, et al. Among authors: cartier l. Clin Transl Radiat Oncol. 2023 Mar 8;40:100613. doi: 10.1016/j.ctro.2023.100613. eCollection 2023 May. Clin Transl Radiat Oncol. 2023. PMID: 36968576 Free PMC article.
[Axillary lymph node irradiation in breast cancer: state of the art].
Auberdiac P, Chargari C, Cartier L, Zioueche A, Mélis A, de Laroche G, Kirova Y, Magné N. Auberdiac P, et al. Among authors: cartier l. Bull Cancer. 2012 Apr 1;99(4):471-7. doi: 10.1684/bdc.2012.1548. Bull Cancer. 2012. PMID: 22450226 Free article. Review. French.
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET.
Gravis G, Autret A, Guibert-Broudic M, Dubergé T, Zemmour C, Carrier P, Salem N, Badinand D, Cartier L, Gross E, Walz J, Pignot G, Brenot-Rossi I. Gravis G, et al. Among authors: cartier l. Clin Genitourin Cancer. 2021 Aug;19(4):346-353. doi: 10.1016/j.clgc.2021.03.004. Epub 2021 Mar 16. Clin Genitourin Cancer. 2021. PMID: 33849812
Dosimetric study of volumetric arc modulation with RapidArc and intensity-modulated radiotherapy in patients with cervical cancer and comparison with 3-dimensional conformal technique for definitive radiotherapy in patients with cervical cancer.
Guy JB, Falk AT, Auberdiac P, Cartier L, Vallard A, Ollier E, Trone JC, Khodri M, Chargari C, Magné N. Guy JB, et al. Among authors: cartier l. Med Dosim. 2016 Spring;41(1):9-14. doi: 10.1016/j.meddos.2015.06.002. Epub 2015 Jul 23. Med Dosim. 2016. PMID: 26212351
Volumetric modulated arc radiotherapy for limited osteosclerotic myeloma.
Robles A, Levy A, Moncharmont C, Farid L, Guy JB, Malkoun N, Cartier L, Chargari C, Guichard I, Talabard JN, de Laroche G, Magné N. Robles A, et al. Among authors: cartier l. World J Radiol. 2013 Apr 28;5(4):173-7. doi: 10.4329/wjr.v5.i4.173. World J Radiol. 2013. PMID: 23671753 Free PMC article.